E-Therapeutics

E-Therapeutics, based in Long Hanborough, England, specializes in integrating computational power with biological data to develop transformative RNAi medicines. Their innovative approach addresses key challenges in drug development, focusing on enhancing biological understanding and improving drug design efficiency.

The company utilizes its proprietary platforms, HepNet and GalOmic, to identify novel gene targets and deliver potent GalNAc siRNA therapeutics specifically to hepatocytes. By advancing a pipeline of first-in-class preclinical candidates, E-Therapeutics aims to tackle unmet medical needs through targeted gene silencing.

Generated from the website